DJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 1.22% to $2.43 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.51% to 46,758.28 and the NASDAQ Composite Index falling 0.28% to 22,780.51.
The stock's fall snapped a two-day winning streak.
Inovio Pharmaceuticals Inc. closed 58.32% short of its 52-week high of $5.83, which the company reached on October 21st.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 1.43% to $188.64, Statera Biopharma Inc. (STAB) rose 100.00% to $0.00, and Pfizer Inc. $(PFE)$ rose 1.07% to $27.37.
Trading volume (776,586) remained 946,598 below its 50-day average volume of 1.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 03, 2025 17:26 ET (21:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.